BMED
iShares Health Innovation Active ETF
Price Chart
Latest Quote
$30.65
-0.15 (-0.49%)
Current Price
| Previous Close | $30.80 |
| Open | $30.64 |
| Day High | $30.65 |
| Day Low | $30.64 |
| Volume | 302 |
Fund Information
| Quarterly Dividend / Yield | N/A / 0.26% |
| Net Assets | $11.03M |
| Expense Ratio | 0.55% |
| Category | Health |
| Fund Family | BlackRock |
| Net Asset Value | $30.83 |
| Premium/Discount | -0.60% |
| Quarterly Dividend Yield | 0.26% |
| P/E Ratio | 29.29 |
| Exchange | PCX |
đ ETF Analysis
Company Data
Financial Ratios
Returns & Margins
Ownership
| Insider & Institutional transactions data not available |
Valuation Ratios
Analyst Data
Technical Indicators
| SMA20 | $30.42 |
| SMA50 | $28.99 |
| SMA200 | $29.36 |
| RSI | 50.88 |
| ATR | 0.3130 |
| Rel Volume | 0.13 |
Performance History
| Week | -0.45% |
| Month | +7.57% |
| Quarter | +5.88% |
| 6 Months | -2.50% |
| YTD | +1.27% |
| Year | +23.26% |
| 3 Years | +24.34% |
| 5 Years | +1.18% |
| 10 Years | +21.66% |
ETF Scoring Not Available
Exchange-traded funds (ETFs) are not scored using our fundamental analysis metrics, as they represent baskets of securities rather than individual companies.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-07-17 | $30.65 | 300 |
| 2026-07-16 | $30.80 | 300 |
| 2026-07-15 | $30.51 | 13,200 |
| 2026-07-14 | $30.39 | 2,900 |
| 2026-07-13 | $30.66 | 500 |
| 2026-07-10 | $30.79 | 3,400 |
| 2026-07-09 | $31.21 | 4,500 |
| 2026-07-08 | $31.03 | 2,700 |
| 2026-07-07 | $31.57 | 2,300 |
| 2026-07-06 | $31.42 | 1,300 |
| 2026-07-02 | $31.54 | 1,800 |
| 2026-07-01 | $30.69 | 100 |
| 2026-06-30 | $30.62 | 1,200 |
| 2026-06-29 | $30.77 | 6,300 |
| 2026-06-26 | $30.58 | 800 |
| 2026-06-25 | $29.92 | 900 |
| 2026-06-24 | $29.40 | 800 |
| 2026-06-23 | $28.87 | 2,300 |
| 2026-06-22 | $28.56 | 500 |
| 2026-06-18 | $28.42 | 700 |
About iShares Health Innovation Active ETF
Under normal market conditions, the fund will invest at least 80% of its net assets plus any borrowings for investment purposes in equity securities of companies principally engaged in the health sciences group of industries. While the fund will invest primarily in companies providing products and services for human health, it may also invest in companies whose products or services relate to the growth or survival of animals and plants.
Period:
Loading...
No financial data available yet. Financial data will be fetched automatically.